Internal Medicine, Gastroenterology · Kansas City, KS
NPI
1619135373
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3901 Rainbow Blvd, Department of Gastroenterology
Kansas City, KS, 66160
Phone (913) 588-3283
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
725 services
Medicare patients, 2024
421
Average age 71
Drug cost, 2024
$1.6M
1,086 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mollie J Jackson was code 45385 (colonoscopy - lesion removal), 119 times for 115 patients. In total Mollie J Jackson billed 725 services in 43 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 119 | 115 | $173.54 | $21K |
| 45380 Lower GI Endoscopy - Other | Facility | 93 | 92 | $66.83 | $6,215 |
| 43239 Upper GI Endoscopy | Facility | 88 | 86 | $51.91 | $4,568 |
| 99222 Hospital E&M - Initial | Facility | 52 | 50 | $99.93 | $5,196 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 29 | $58.68 | $2,054 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 32 | 28 | $12.77 | $409 |
| 43235 Upper GI Endoscopy | Facility | 31 | 31 | $73.25 | $2,271 |
| 99214 Office E&M - Established | Facility | 30 | 27 | $65.04 | $1,951 |
| 43248 Upper GI Endoscopy | Facility | 29 | 28 | $95.47 | $2,769 |
| 99215 Office E&M - Established | Facility | 22 | 20 | $105.31 | $2,317 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $127.89 | $2,302 |
| 99205 Office E&M - New | Facility | 17 | 17 | $130.93 | $2,226 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $132.10 | $2,114 |
| 99204 Office E&M - New | Facility | 15 | 15 | $95.64 | $1,435 |
| 43249 Upper GI Endoscopy | Facility | 12 | 12 | $63.66 | $764 |
By year: 2022 $63K for 679 services; 2023 $68K for 742 services; 2024 $68K for 725 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mollie J Jackson prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 118 prescriptions and refills. In total Mollie J Jackson wrote 1,086 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 118 | 118 | 115 | $2,495 |
| Omeprazole Generic | 101 | 232 | 45 | $1,492 |
| Pantoprazole Sodium Generic | 76 | 194 | 30 | $1,871 |
| Famotidine Generic | 73 | 185 | 26 | $910 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 68 | 68 | 66 | $1,091 |
| Humira(Cf) Pen Adalimumab | 48 | 48 | Under 11 | $577K |
| Esomeprazole Magnesium Generic | 41 | 67 | 12 | $1,320 |
| Ondansetron Odt Ondansetron | 37 | 45 | 16 | $1,445 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 35 | 35 | 30 | $562 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 34 | 34 | 32 | $2,290 |
| Dicyclomine Hcl Generic | 30 | 52 | 12 | $672 |
| Creon Lipase/Protease/Amylase | 27 | 33 | Under 11 | $83K |
| Budesonide Dr Budesonide | 26 | 69 | Under 11 | $7,730 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 20 | 23 | Under 11 | $5,095 |
| Stelara Ustekinumab | 20 | 28 | Under 11 | $496K |
Brand drugs: - claims; generic drugs: 778 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mollie J Jackson were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.